• 1263 Citations
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

The Perera laboratory focuses on pharmacogenomics (using a patient's genome to predict drug response) in minority populations. Working in this translation research space requires both clinical expertise as well as the use of high-throughput basic science approaches. Our goal is to bring the benefits of precision medicine to all US populations.

Training Experience

2006Postdoctoral Fellowship, University of Chicago

Education/Academic qualification

PhD, Ohio State University

… → 2003

PharmD, University of Tennessee, Knoxville

… → 2001

Research interests

  • Adverse Drug Reactions
  • Autoimmune Diseases
  • Gene Regulation
  • Genomic Medicine/Personalized Medicine
  • Inflammatory Bowel Disease
  • Pharmacogenomics
  • Pharmacology

Fingerprint Dive into the research topics where Minoli Perera is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    Discovery of novel hepatocyte eQTLs in African Americans

    Zhong, Y., De, T., Alarcon, C., Sehwan Park, C., Lec, B. & Perera, M. A., Apr 2020, In : PLoS genetics. 16, 4, e1008662.

    Research output: Contribution to journalArticle

    Open Access
  • Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis

    Asiimwe, I. G., Zhang, E. J., Osanlou, R., Krause, A., Dillon, C., Suarez-Kurtz, G., Zhang, H., Perini, J. A., Renta, J. Y., Duconge, J., Cavallari, L. H., Marcatto, L. R., Beasly, M. T., Perera, M. A., Limdi, N. A., Santos, P. C. J. L., Kimmel, S. E., Lubitz, S. A., Scott, S. A., Kawai, V. K. & 2 others, Jorgensen, A. L. & Pirmohamed, M., Jun 1 2020, In : Clinical pharmacology and therapeutics. 107, 6, p. 1420-1433 14 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Impact of CYP2C9-Interacting Drugs on Warfarin Pharmacogenomics

    Agrawal, S., Heiss, M. S., Fenter, R. B., Abramova, T. V., Perera, M. A., Pacheco, J. A., Smith, M. E., Rasmussen-Torvik, L. J. & George, A. L., Jan 1 2020, (Accepted/In press) In : Clinical and Translational Science.

    Research output: Contribution to journalArticle

    Open Access
  • Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation

    Hernandez, W., Danahey, K., Pei, X., Yeo, K. T. J., Leung, E., Volchenboum, S. L., Ratain, M. J., Meltzer, D. O., Stranger, B. E., Perera, M. A. & O’Donnell, P. H., Feb 1 2020, In : Pharmacogenomics Journal. 20, 1, p. 126-135 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Why African Americans say "no": A study of pharmacogenomic research participation

    Nooruddin, M., Scherr, C., Friedman, P., Subrahmanyam, R., Banagan, J., Moreno, D., Sathyanarayanan, M., Nutescu, E., Jeyaram, T., Harris, M., Zhang, H., Rodriguez, A., Shaazuddin, M., Perera, M. & Tuck, M., 2020, In : Ethnicity and Disease. 30, p. 159-166 8 p.

    Research output: Contribution to journalReview article

    Open Access